Cytheris Scientific Publications/Abstracts/Posters -- HCV
“IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology” by Marc Pellegrini, Thomas Calzascia, Jesse G. Toe, Simon P. Preston, Amy E. Lin, Alisha R. Elford, Arda Shahinian, Philipp A. Lang, Karl S. Lang, Michel Morre, Brigitte Assouline, Katharina Lahl, Tim Sparwasser, Thomas F. Tedder, Ji-hye Paik, Ronald A. DePinho, Sameh Basta, Pamela S. Ohashi, and Tak W. Mak, 2011. Cell, Vol. 144, No. 4:601-613. (View Abstract on Pubmed)
"IL-7 Knocks the Socs Off Chronic Viral Infection" Ian A. Parish and Susan M. Kaech. 2011. Cell, Vol. 144, No. 4: 467-468. (View Abstract on Pubmed)
AASLD 2011
Habersetzer F, Payen JL, Rouzier R, Alric L, Andreone P, Grando V, Attali P, Hézode C, Serfaty L, Tambussi G, Thabut D, Beq S, Demol P, Croughs T, Morre M, Marcellin P. Four weeks of IL-7 (CYT107) added to peginterferon and ribavirin (SOC) induces a broad immune response associated with HCV viral clearance in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC. The Liver Meeting®, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011. (Abstract #LB-9). (View Poster)